Clinical Trial

Cannabidiol and Alcohol Use Disorder Phenotypes

Name: Cannabidiol and Alcohol Use Disorder Phenotypes — clinical trial record (NCT07279558)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: CAP

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The goal of this study is to learn how CBD affects drinking in people who drink alcohol regularly. Researchers want to see if CBD can help people drink less and reduce problems related to alcohol use.

Protocol Amendment History 2 changes

critical Recruitment opened 2026-04-04

notable Enrollment reduced: 180 -> 150 participants 2026-04-04

Trial Details

NCT Number	NCT07279558
Lead Sponsor	University of Colorado, Denver Collaborators: National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Conditions	Alcohol Use Disorder
Enrollment	150 participants
Start Date	2026-03-31
Primary Completion	2029-08-31 (estimated)
Study Completion	2029-08-31 (estimated)
Updated on ClinicalTrials.gov	2026-04-03